Beste apotheek van Nederland

Greenstein A, Plymate S R, Katz P G. Visually stimulated
erection in castrated men. Br J Urol 1995;153(3:Pt 1):t-2.
Gresser U, Gleiter C H. Erectile dysfunction: comparison of
efficacy and side effects of the PDE-5 inhibitors sildenafil,
vardenafil and tadalafil--review of the literature. [Review] [92
refs]. Eur J Med Res 2002;7(10):435-446.
Gross A J, Sauerwein D H, Kutzenberger J et al. Penile
prostheses in paraplegic men. Br J Urol 1996;78(2):262-264.
Grover J K, Vats V, Ajeeta. Sildenafil (Viagra(TM)). Medico-
Legal Update 1998;3(1-2):67-78.
Grugni G, Carani C, Maestroni G et al. Melatonin levels in
psychogenic impotence. Hormone & Metabolic Research
1994;26(9):440-441.
Grunwald J E, Jacob S S, Siu K et al. Acute effects of sildenafil
citrate (Viagra) on intraocular pressure in open-angle glaucoma.
Am J Ophthalmol 2001;132(6):872-874.
Gryglewska B, Grodzicki T. Betaxolol in elderly patients in
primary care. New Medicine 2003;6(4):108-111.
Guay A T, Sabharwal P, Varma S et al. Delayed diagnosis of
psychological erectile dysfunction because of the presence of
macroprolactinemia. Journal of Clinical Endocrinology &
Metabolism 1996;81(7):2512-2514.
Guay D R P. Geriatric pharmacotherapy updates. American
Journal Geriatric Pharmacotherapy 2004;2(1):81-87.
Guirguis W R, Maytom M C, Orr M et al. SILDENAFIL FOR
ERECTILE DYSFUNCTION - A ONE-YEAR STUDY. 151st
Annual Meeting of the American Psychiatric Association
1998;Toronto, Ontario, Canada. 30th May-4th June. 1998. Issue
No. 63, 1998.
Guo Y L, Zhu J C, Pan T M et al. Efficacy and safety of oral
sildenafil in the treatment of erectile dysfunction. Chinese
Journal of Urology 2001;22(7):389-394.
Gupta N, Sawlani K K, Tripathi A K. Appropriate use of
sildenafil citrate in male erectile dysfunction.[see comment].
[Review] [52 refs]. J Assoc Physicians India 2001;49889-896.
Gupta S, Salimpour P, Saenz de et al. A possible mechanism for
alteration of human erectile function by digoxin: inhibition of
corpus cavernosum sodium/potassium adenosine triphosphatase
activity. Br J Urol 1998;159(5):1529-1536.
Hackett G I. The treatment of patients with diabetes. Int J STD
AIDS 1996;7(Suppl 3):24-26.
Haensel S M, Klem T M, Hop W C et al. Fluoxetine and
premature ejaculation: a double-blind, crossover, placebocontrolled
study. J Clin Psychopharmacol 1998;18(1):72-77.
Haensel S M, Rowland D L, Kallan K T. Clomipramine and
sexual function in men with premature ejaculation and controls.
Br J Urol 1996;156(4):1310-1315.
Hamed S, Mohamed K, El-taher A et al. The sexual
and reproductive health in men with generalized
epilepsy: A multidisciplinary evaluation. Int J Impot
Res 2006;18(3):287-295.
Hammadeh M Y, Philp T. Transurethral
electrovaporization of the prostate (TUVP) is
effective, safe and durable. [Review] [28 refs].
Prostate Cancer & Prostatic Diseases 2003;6(2):121­
126.
Hammadeh M Y, Madaan S, Hines J et al. 5-year
outcome of a prospective randomized trial to compare
transurethral electrovaporization of the prostate and
standard transurethral resection. Urology
2003;61(6):1166-1171.
Hanash K A. Comparative results of goal oriented
therapy for erectile dysfunction.. Br J Urol
1997;157(6):2135-2138.
Harman S M. Testosterone, Sexuality, and Erectile
Function in Aging Men. J Androl 2003;24(6
SUPPL.):S42-S45.
Hartmann Uwe, Langer Dieter. Combination of
psychosexual therapy and intrapenile injections in the
treatment of erectile dysfunctions: Rationale and
predictors of outcome. J Sex Educ Ther 1993;19(1):1­
12.
Harwood P J, Grotz M, Eardley I et al. Erectile
dysfunction after fracture of the pelvis. Journal of
Bone & Joint Surgery - British Volume
2005;87(3):281-290.
Haslam M T. A trial of idazoxan and yohimbine in
erectile dysfunction. Sex Marital Ther 1992;7(3):261­
266.
Hatzichristou D G. Sildenafil citrate: lessons learned
from 3 years of clinical experience. [Review] [60
refs]. Int J Impot Res 2002;14Suppl-52.
Hatzichristou D G. Current treatment and future
perspectives for erectile dysfunction. [Review] [85
refs]. Int J Impot Res 1998;10Suppl-13.
Hatzimouratidis K, Hatzichristou D. Testosterone and
erectile function: an unresolved enigma. Eur Urol
2007;52(1):26-28.
Hatzimouratidis K, Hatzichristou D.
Phosphodiesterase Type 5 Inhibitors: The Day After.
Eur Urol 2007;51(1):75-89.
Hatzimouratidis K, Hatzichristou D G. A comparative
review of the options for treatment of erectile
dysfunction: Which treatment for which patient?.
Drugs 2005;65(12):1621-1650.
D-67